Brain in Focus of Arterial Hypertension: Minimizing Negative Prognosis

Announcement:

The brain at the center of arterial hypertension: how to minimize the risk of cognitive impairment? For the attention of therapists, neurologists, and general practitioners, Vadim Vitalyevich Tyrenko, Head of the Department of Faculty Therapy at the S.M. Kirov Military Medical Academy, Chief Cardiologist of the Russian Ministry of Defense, and Chief Pulmonologist of the Health Committee of the Government of St. Petersburg, will speak at a conference for primary care physicians. He will discuss:

• Why are cognitive impairments not a late complication, but the earliest sign of brain damage in hypertension?
• Which current clinical guidelines already include assessment of cognitive function in patients with hypertension?
• Which screening tests (Mini-Cog, MoCA, MMSE, clock drawing test) can realistically be used in a therapist's office visit - and how to interpret the results?
• Why is blood pressure control not only about stroke prevention but also about protecting cognitive functions?
• Which classes of antihypertensive drugs show a brain protective advantage?
• Why is antihypertensive therapy alone not enough – and why is neuroprotection needed?

The report provides a detailed analysis of the MEMO study, which confirmed the effectiveness of the drug Mexidol in patients with chronic cerebral ischemia and arterial hypertension.

The drug is included in clinical guidelines for ischemic stroke and cognitive impairment in the elderly, and the resolution of the Expert Council emphasizes the need to include neuroprotection in the standard of care for patients with hypertension.

 Watch the full report to find out:

• How to diagnose cognitive impairment at the earliest stages;
• Why does memory suffer differently in vascular disorders than in Alzheimer's disease;
• How to build a comprehensive strategy: from blood pressure control to neuroprotection.

The video lecture is a must-see for anyone who treats patients with hypertension, especially the elderly and those with polymorbidity.